Redmile Biopharma Investments III, L.P. (CIK 1838746) reported 3 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-07). Recent activity: Buy ATTO (782,854 shares), Buy ATTO (200,000 shares), Buy ATTO (400,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-07 | Attovia Therapeutics, Inc. (ATTO) | 10% Owner | Buy | 782,854 | $0 |
| 2026-08-07 | Attovia Therapeutics, Inc. (ATTO) | 10% Owner | Buy | 200,000 | $3.4M |
| 2026-08-07 | Attovia Therapeutics, Inc. (ATTO) | 10% Owner | Buy | 400,000 | $6.8M |
Source: SEC Form 4 filings · as of 2026-08-07